Guo-Qiang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Guo-Qiang Wang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Weiwei Zhang
Department of Nephrology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, People’s Republic of China
3 shared publications - Yonghua Huang
The Seventh Medical Center, Chinese PLA General Hospital
3 shared publications Hai-Xia Wang
The Seventh Medical Center of Chinese PLA General Hospital
2 shared publicationsNan Zhang
The Seventh Medical Center of Chinese PLA General Hospital
2 shared publications- Gang Lv
Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100091, China
1 shared publication - Hai-Xia Wang
Department of Neurology, Chinese PLA Army General Hospital, Beijing, 100700, China
1 shared publication
Latest Publications
- Open Access
- 28 September 2023
- Published by Springer Nature in Research Square
Prognostic analysis of atrial fibrillation patients with acute cerebral infarction: a retrospective study of 330 cases over a 10-year period
Background: The neurologic outcome of atrial fibrillation (AF) patients with acute ischemic stroke (AIS) is usually worse than those without AF. The aim of our study was to evaluate prognostic factors in AF-AIS. Methods We retrospectively collected information about AF-AIS patients admitted to our department from Jan. 2013 and Aug. 2023. According to the modified Rankin Scale (mRS) score at discharge, patients were divided into two groups: group A with favorable outcomes (mRS ≤ 2,) and group B with poor outcomes (mRS > 2). Results A total of 330 AF-AIS patients met the inclusion criteria, including 95 in group A and 235 in group B. The large-, medium- and small-infarct sizes were 45.5%, 31.5% and 23.0%, respectively. Intravenous alteplase thrombolysis (IV-rtPA) was prescribed to 69 patients. Parenchymal hemorrhage (PH) was present in 53 (16.1%) patients. The incidence of PH for patients with IV-rtPA was 34.8% (24/69), and 17.9% (45/251) for no-IV-rtPA patients. In univariate analysis, older age, higher NIHSS score and glucose, lower level of triglyceride, lager infarct size and PH were all associated with a poor outcome. No difference was found between the good and poor outcomes with IV-rtPA (18.9% vs. 21.7%, p = 0.578). In multivariate analysis, age (OR 1.059, 95% CI 1.024–1.094, p = 0.001), NIHSS score (OR 1.305, 95% CI 1.210–1.407, p < 0.001), infarct size (OR 2.485, 95% CI 1.018–6.062, p = 0.045), glucose (OR 1.994, 95% CI 1.011–3.933, p = 0.046) and PH (OR 4.130, 95% CI 1.303–13.092, p = 0.016) were independently associated with poor outcome. And, large infarct size (OR 3.786, 95% CI 1.912–7.459, p < 0.001), IV-rtPA (OR 4.904, 95% CI 2.452–9.808, p < 0.001), lower baseline level of triglyceride (OR 3.797, 95% CI 1.636–8.817, p = 0.002) and diabetes mellitus (OR 2.973, 95% CI 1.477–5.983, p = 0.002) were significantly associated with the development of PH. Conclusion The majority of AF-AIS patients had a poor outcome, which was independently associated with age, NIHSS score, infarct size, glucose and PH. IV-rtPA was related to an increased risk of PH and failed to improve overall short-term outcomes, especially for those with a large infarct size, a lower level of baseline triglyceride and a history of diabetes mellitus.
- 28 September 2023
- Published by Springer Nature in Research Square
Open AccessPrognostic analysis of atrial fibrillation patients with acute cerebral infarction: a retrospective study of 330 cases over a 10-year period
Background: The neurologic outcome of atrial fibrillation (AF) patients with acute ischemic stroke (AIS) is usually worse than those without AF. The aim of our study was to evaluate prognostic factors in AF-AIS. Methods We retrospectively collected information about AF-AIS patients admitted to our department from Jan. 2013 and Aug. 2023. According to the modified Rankin Scale (mRS) score at discharge, patients were divided into two groups: group A with favorable outcomes (mRS ≤ 2,) and group B with poor outcomes (mRS > 2). Results A total of 330 AF-AIS patients met the inclusion criteria, including 95 in group A and 235 in group B. The large-, medium- and small-infarct sizes were 45.5%, 31.5% and 23.0%, respectively. Intravenous alteplase thrombolysis (IV-rtPA) was prescribed to 69 patients. Parenchymal hemorrhage (PH) was present in 53 (16.1%) patients. The incidence of PH for patients with IV-rtPA was 34.8% (24/69), and 17.9% (45/251) for no-IV-rtPA patients. In univariate analysis, older age, higher NIHSS score and glucose, lower level of triglyceride, lager infarct size and PH were all associated with a poor outcome. No difference was found between the good and poor outcomes with IV-rtPA (18.9% vs. 21.7%, p = 0.578). In multivariate analysis, age (OR 1.059, 95% CI 1.024–1.094, p = 0.001), NIHSS score (OR 1.305, 95% CI 1.210–1.407, p < 0.001), infarct size (OR 2.485, 95% CI 1.018–6.062, p = 0.045), glucose (OR 1.994, 95% CI 1.011–3.933, p = 0.046) and PH (OR 4.130, 95% CI 1.303–13.092, p = 0.016) were independently associated with poor outcome. And, large infarct size (OR 3.786, 95% CI 1.912–7.459, p < 0.001), IV-rtPA (OR 4.904, 95% CI 2.452–9.808, p < 0.001), lower baseline level of triglyceride (OR 3.797, 95% CI 1.636–8.817, p = 0.002) and diabetes mellitus (OR 2.973, 95% CI 1.477–5.983, p = 0.002) were significantly associated with the development of PH. Conclusion The majority of AF-AIS patients had a poor outcome, which was independently associated with age, NIHSS score, infarct size, glucose and PH. IV-rtPA was related to an increased risk of PH and failed to improve overall short-term outcomes, especially for those with a large infarct size, a lower level of baseline triglyceride and a history of diabetes mellitus.
- Open Access
- 15 June 2021
- Published by Springer Nature in Research Square
Influences of Intravenous Thrombolysis with Recombinant Tissue-type Plasminogen Activator on the Outcome of Atrial Fibrillation Patients with Acute Ischemic Stroke: A Case a Case-control Study of 227 Patients
Background: It is a debatable topic about the benefit of intravenous (IV) thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) for atrial fibrillation (AF) patients with acute ischemic stroke (AIS). This study aimed to identify whether IV rt-PA could improve the short-term outcome of patients with AF-AIS.Methods: Medical data of patients with AIS onset within 72hs admitted in the department of neurologic of our hospital between January 1st, 2015 and December 31, 2020 were extracted. The AF-AIS patients were selected and divided into IV rt-PA group (group A) and non-rt-PA group (group B). The baseline characteristics, imaging changes and modified Rankin Scale (mRS) score (≤ 2 as good prognosis, > 2 as poor, = 6 as death) at discharge were obtained to compare the differences between the two groups. Logistic regression was used to analyze the factors influencing on the outcome. Results: Among a total of 1663 AIS patients, there were 280 had AF, of them 227 AF-AIS cases were conformed to the inclusion criteria, including 45 in group A and 182 in group B. All of AF-AIS patients, 48.0% had larger size of infarction and 62.1% had National Institute of Health stroke scale (NIHSS)score more than 10, the differences in the size and NIHSS between the two groups were not significant. A total of 51 cases (22.5%) died during hospitalization, the difference between group A and group B was not obvious (20.0% vs. 23.1%, P=0.658). The cumulative poor outcome (including deaths) at discharge was 75.3%, the difference between the two groups was also not significant (77.8% vs. 74.7%, P=0.671). The incidence of hemorrhagic transformation (HT) in group A was higher than that of in group B (40.0% vs. 21.4, P=0.010), the same was true for parenchymal hematoma (PH) in group A than group B (22.2% vs. 5.5%, P = 0.001). On univariate analysis, poor outcome was significantly associated with infarct size, NIHSS and PH, but not thrombolysis. The proportion of PH in patients with poor outcome between the two groups was also not remarkable. On adjusted multiple logistic regression analysis, both baseline infarction size [(P=0.013, odds ratio (OR) =4.558, 95% 95% confidence interval (CI): 1.373- 15.133] and NIHSS (PConclusion: Patients with AF-AIS had larger infarction size, higher NIHSS score, higher rate of mortality and worse outcome, for them, the IV rt-PA increased the incidence of PH except significantly improved their short-term prognosis.
- 15 June 2021
- Published by Springer Nature in Research Square
Open AccessInfluences of Intravenous Thrombolysis with Recombinant Tissue-type Plasminogen Activator on the Outcome of Atrial Fibrillation Patients with Acute Ischemic Stroke: A Case a Case-control Study of 227 Patients
Background: It is a debatable topic about the benefit of intravenous (IV) thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) for atrial fibrillation (AF) patients with acute ischemic stroke (AIS). This study aimed to identify whether IV rt-PA could improve the short-term outcome of patients with AF-AIS.Methods: Medical data of patients with AIS onset within 72hs admitted in the department of neurologic of our hospital between January 1st, 2015 and December 31, 2020 were extracted. The AF-AIS patients were selected and divided into IV rt-PA group (group A) and non-rt-PA group (group B). The baseline characteristics, imaging changes and modified Rankin Scale (mRS) score (≤ 2 as good prognosis, > 2 as poor, = 6 as death) at discharge were obtained to compare the differences between the two groups. Logistic regression was used to analyze the factors influencing on the outcome. Results: Among a total of 1663 AIS patients, there were 280 had AF, of them 227 AF-AIS cases were conformed to the inclusion criteria, including 45 in group A and 182 in group B. All of AF-AIS patients, 48.0% had larger size of infarction and 62.1% had National Institute of Health stroke scale (NIHSS)score more than 10, the differences in the size and NIHSS between the two groups were not significant. A total of 51 cases (22.5%) died during hospitalization, the difference between group A and group B was not obvious (20.0% vs. 23.1%, P=0.658). The cumulative poor outcome (including deaths) at discharge was 75.3%, the difference between the two groups was also not significant (77.8% vs. 74.7%, P=0.671). The incidence of hemorrhagic transformation (HT) in group A was higher than that of in group B (40.0% vs. 21.4, P=0.010), the same was true for parenchymal hematoma (PH) in group A than group B (22.2% vs. 5.5%, P = 0.001). On univariate analysis, poor outcome was significantly associated with infarct size, NIHSS and PH, but not thrombolysis. The proportion of PH in patients with poor outcome between the two groups was also not remarkable. On adjusted multiple logistic regression analysis, both baseline infarction size [(P=0.013, odds ratio (OR) =4.558, 95% 95% confidence interval (CI): 1.373- 15.133] and NIHSS (PConclusion: Patients with AF-AIS had larger infarction size, higher NIHSS score, higher rate of mortality and worse outcome, for them, the IV rt-PA increased the incidence of PH except significantly improved their short-term prognosis.
- Open Access
- 22 January 2019
- Published by Elsevier in Military Medical Research
- Vol. 6 (1) , 2
Influences of blood lipids on the occurrence and prognosis of hemorrhagic transformation after acute cerebral infarction: a case-control study of 732 patients
- 22 January 2019
- Published by Elsevier in Military Medical Research
- Vol. 6 (1) , 2
Open AccessInfluences of blood lipids on the occurrence and prognosis of hemorrhagic transformation after acute cerebral infarction: a case-control study of 732 patients
- Open Access
- 1 January 2014
- Published by Elsevier in Military Medical Research
- Vol. 1 (1) , 1-12
Can minimally invasive puncture and drainage for hypertensive spontaneous Basal Ganglia intracerebral hemorrhage improve patient outcome: a prospective non-randomized comparative study
- 1 January 2014
- Published by Elsevier in Military Medical Research
- Vol. 1 (1) , 1-12
Open AccessCan minimally invasive puncture and drainage for hypertensive spontaneous Basal Ganglia intracerebral hemorrhage improve patient outcome: a prospective non-randomized comparative study
- Open Access
- 29 July 2013
- Published by Springer Nature in BMC Neurology
- Vol. 13 (1) , 100
Spontaneous intracranial hemorrhage as an initial manifestation of primary Sjögren’s syndrome: a case report
Sjögren’s syndrome can involve the central nervous system; however, spontaneous intracranial hemorrhage has rarely been reported as the initial manifestation.
- 29 July 2013
- Published by Springer Nature in BMC Neurology
- Vol. 13 (1) , 100
Open AccessSpontaneous intracranial hemorrhage as an initial manifestation of primary Sjögren’s syndrome: a case report
Sjögren’s syndrome can involve the central nervous system; however, spontaneous intracranial hemorrhage has rarely been reported as the initial manifestation.